Screener
Roivant Sciences ROIV Investments Fair Value Disclosure
Investments Fair Value Disclosure at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept us-gaap:InvestmentsFairValueDisclosure.
The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001635088-26-000090
| Line item | June 30, 2026 | March 31, 2026 |
|---|---|---|
| Total current assets | 4,742,080 | 5,167,384 |
| Property and equipment, net | 11,320 | 11,986 |
| Operating lease right-of-use assets | 78,886 | 80,416 |
| Investments measured at fair value | 444,622 | 407,985 |
| Other assets | 29,585 | 40,916 |
| Total assets | $5,306,493 | $5,708,687 |
| Liabilities and Shareholders’ Equity | ||
| Current liabilities: |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Roivant Sciences's investments fair value disclosure?
- Roivant Sciences (ROIV) reported investments fair value disclosure of $444.62M in Q2 2026.
- How has Roivant Sciences's investments fair value disclosure changed year-over-year?
- Roivant Sciences's investments fair value disclosure increased by 56.7% year-over-year, from $283.81M to $444.62M.
- What is the long-term trend for Roivant Sciences's investments fair value disclosure?
- Over 5 years (2020 to 2025), Roivant Sciences's investments fair value disclosure has grown at a 16.6% compound annual growth rate (CAGR), from $188.98M to $407.99M.
- What does investments fair value disclosure mean?
- Investments Fair Value Disclosure
Ask your AI about Roivant Sciences's investments fair value disclosure.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude